Vertex Pharmaceuticals
VRTX | NASDAQ
$555.64
-$3.24 (-0.58%)
Nov 2, 2026, 3:57 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.33B | 2.99B | 3.23B | 3.08B | 2.96B | 2.77B | 2.91B | 2.77B | 2.65B | 2.69B | 2.52B | 2.48B | 2.49B | 2.37B | 2.3B | 2.33B | 2.2B | 2.1B | 2.07B | 1.98B | 1.79B | 1.72B |
Cost of Revenue | 489.2M | 392.8M | 466M | 414.8M | 407.5M | 363M | 423.4M | 392.6M | 371.9M | 342.6M | 368M | 318.7M | 308.6M | 266.9M | 283.3M | 289.4M | 261.8M | 245.8M | 247.4M | 236.51M | 227.97M | 192.33M |
Gross Profit | 2.84B | 2.59B | 2.76B | 2.66B | 2.56B | 2.41B | 2.49B | 2.38B | 2.27B | 2.34B | 2.15B | 2.16B | 2.18B | 2.11B | 2.02B | 2.04B | 1.93B | 1.85B | 1.83B | 1.75B | 1.57B | 1.53B |
Operating Income | 1.25B | 1.14B | 1.3B | 1.19B | 1.15B | 630.1M | 1.03B | 1.12B | -3.51B | 1.14B | 988.5M | 1.04B | 1.03B | 779M | 1.03B | 1.13B | 1.11B | 1.04B | 877.7M | 1.05B | -37.9M | 887.83M |
Interest Income | 120.6M | 114.8M | 121.9M | 125.7M | 122.4M | 120.9M | 128.2M | 132.2M | 156.5M | 181.2M | 179.5M | 167.9M | 144.7M | 122.6M | 86M | 46.2M | 10.8M | 1.6M | 1.2M | 1.12M | 1.13M | 1.47M |
Pretax Income | 1.39B | 1.25B | 1.33B | 1.3B | 1.28B | 730.4M | 1.14B | 1.22B | -3.39B | 1.28B | 1.15B | 1.18B | 1.16B | 891.5M | 1.08B | 1.18B | 1.02B | 954.8M | 870.9M | 1.08B | -44.2M | 820.96M |
Net Income | 1.1B | 1.03B | 1.19B | 1.08B | 1.03B | 646.3M | 913M | 1.05B | -3.59B | 1.1B | 968.8M | 1.04B | 915.7M | 699.8M | 818.9M | 930.5M | 810.5M | 762.1M | 770.1M | 851.93M | 66.92M | 653.14M |
Selling & General & Admin | 582.2M | 493.7M | 487M | 445.1M | 424.6M | 396.4M | 377.6M | 371.8M | 372.2M | 342.7M | 369.1M | 263.8M | 262.6M | 241.1M | 267.4M | 246.8M | 215.3M | 215.2M | 255.2M | 198.19M | 194.6M | 192.08M |
Research & Development | 993.8M | 961.6M | 973.7M | 1.03B | 978.4M | 979.7M | 998.7M | 875.9M | 5.42B | 865.9M | 1.35B | 861.7M | 896.2M | 742.6M | 694.1M | 645M | 600.1M | 603.1M | 694.3M | 493.75M | 1.41B | 455.97M |
Other Expenses | 21.8M | 700K | n/a | -1.9M | 3.1M | 401M | 86.3M | 15.3M | 500K | -100K | -559.6M | n/a | 1.6M | 345.2M | 24.4M | 26.4M | 12.7M | -7.5M | n/a | n/a | 1.6M | n/a |
Operating Expenses | 1.6B | 1.46B | 1.46B | 1.48B | 1.41B | 1.78B | 1.46B | 1.26B | 5.79B | 1.21B | 1.16B | 1.13B | 1.16B | 1.33B | 985.9M | 918.2M | 828.1M | 810.8M | 949.5M | 691.94M | 1.6B | 648.05M |
Interest Expense | n/a | n/a | 3.3M | 3.3M | 3.7M | 3M | 2.8M | 7.5M | 9.9M | 10.4M | 10.6M | 10.9M | 11.2M | 11.4M | 11.6M | 13.7M | 14.6M | 14.9M | 15.1M | 15.26M | 15.48M | 15.68M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.09B | 1.85B | 1.93B | 1.89B | 1.81B | 2.14B | 1.89B | 1.66B | 6.16B | 1.55B | 1.53B | 1.45B | 1.47B | 1.6B | 1.27B | 1.21B | 1.09B | 1.06B | 1.2B | 928.45M | 1.83B | 840.38M |
Income Tax Expense | 292M | 221.5M | 139.9M | 215.9M | 250.1M | 84.1M | 223.5M | 178.7M | 202.4M | 179.5M | 178.8M | 143.9M | 245.8M | 191.7M | 257.9M | 245.9M | 213.9M | 192.7M | 100.8M | 230.81M | -111.18M | 167.82M |
Shares Outstanding (Basic) | 253.9M | 254.1M | 253.9M | 255.6M | 256.7M | 256.9M | 257.5M | 258M | 258.1M | 258.2M | 257.7M | 258M | 257.7M | 257.4M | 256.9M | 256.5M | 255.9M | 255.1M | 254.6M | 257.88M | 258.99M | 259.37M |
Shares Outstanding (Diluted) | 255.7M | 256.3M | 256.1M | 257.6M | 258.9M | 259.5M | 260.5M | 261M | 258.1M | 261.1M | 260.9M | 260.6M | 260.4M | 260.3M | 260.3M | 259.5M | 258.7M | 257.9M | 257M | 259.71M | 261.02M | 261.92M |
EPS (Basic) | 4.33 | 4.06 | 4.69 | 4.24 | 4.02 | 2.52 | 3.55 | 4.05 | -13.92 | 4.26 | 3.76 | 4.01 | 3.55 | 2.72 | 3.19 | 3.63 | 3.17 | 2.99 | 3.02 | 3.30 | 0.26 | 2.52 |
EPS (Diluted) | 4.31 | 4.02 | 4.65 | 4.20 | 3.99 | 2.49 | 3.50 | 4.01 | -13.92 | 4.21 | 3.71 | 3.97 | 3.52 | 2.69 | 3.15 | 3.59 | 3.13 | 2.96 | 3 | 3.28 | 0.26 | 2.49 |
EBITDA | 1.39B | 1.31B | 1.39B | 1.36B | 1.34B | 781.8M | 1.18B | 1.28B | -3.33B | 1.34B | 1.22B | 1.23B | 1.21B | 941.7M | 1.13B | 1.23B | 1.08B | 1.01B | 919.83M | 1.13B | 2.6M | 865.47M |
EBIT | 1.39B | 1.25B | 1.33B | 1.3B | 1.29B | 733.4M | 1.14B | 1.23B | -3.38B | 1.29B | 1.16B | 1.19B | 1.17B | 902.9M | 1.09B | 1.19B | 1.04B | 969.7M | 886.04M | 1.1B | -28.7M | 836.64M |
Depreciation & Amortization | n/a | 55.9M | 53.1M | 54M | 51.7M | 48.4M | 46.5M | 53.2M | 54M | 53.5M | 59M | 42.1M | 41.4M | 38.8M | 38.4M | 36.7M | 37.3M | 35.9M | 33.83M | 31.7M | 31.3M | 28.83M |
Add to Watchlist
Select watchlists to add or remove VRTX